Russian Pharma Sector Forecast to 2013

The Russian pharma industry is emerging as one of the leading sectors in the healthcare industry, showing an unprecedented growth of around 21% to generate revenue of about US$ 22.2 Billion in 2009. This surge is primarily accredited to the state drug development incentives that have supported the industry to sustain its growth pace. Besides, the government is investing funds in research and development (R&D) and high innovative products to make the industry more competitive and self reliant instead of dependable on imports. The parapharmaceuticals segment has become one of the leading segments benefited from strong young population demand.

According to our new research report “Russian Pharma Sector Forecast to 2013”, the Russian pharma sector is projected to show double-digit growth in near future owing to a rise in investments by the private sector. As majority of the drugs used in the Russian Federation are imported, private players have started investing in research and development projects to manufacture more generic drugs that are less expensive. To support this evidence, we have done an extensive research and analysis of various segments of the pharma market in the Russian Federation. These segments include: Commercial Drug Segment, State Segment and the Parapharmaceutical Segment.

The baseline for optimistic future outlook of our report is that the Russian population has become more health conscious. Due to the rising prevalence of diseases, old age population and healthcare expenditure, the demand for drugs will rise in coming years. Improvement in the healthcare industry will pave the way for the Russian pharma market to continue its upward trend over the forecast period (2010-2013).

The report provides precise and reliable information, supplemented with statistics, about the Russian pharma sector. The report covers leading drugs, segment-wise break up, and information about major therapy areas. It has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecast has been done considering the possible impact of post-recession on the industry.

The report also gives a brief overview of demographics and healthcare profile to adjudge the pharmaceutical market in terms of demands, expenditure and possible future direction.

For more detail visit :- http://www.marketsmonitor.com/Russian-Pharma-Sector-Forecast-to-2013-Report/IM243.htm